Literature DB >> 15287722

Catalysis and function of the p38 alpha.MK2a signaling complex.

Susan M Lukas1, Rachel R Kroe, Jessi Wildeson, Gregory W Peet, Lee Frego, Walter Davidson, Richard H Ingraham, Christopher A Pargellis, Mark E Labadia, Brian G Werneburg.   

Abstract

The p38 mitogen-activated protein kinase (p38) pathway is required for the production of proinflammatory cytokines (TNFalpha and IL-1) that mediate the chronic inflammatory phases of several autoimmune diseases. Potent p38 inhibitors, such as the slow tight-binding inhibitor BIRB 796, have recently been reported to block the production of TNFalpha and IL-1beta. Here we analyze downstream signaling complexes and molecular mechanisms, to provide new insight into the function of p38 signaling complexes and the development of novel inhibitors of the p38 pathway. Catalysis, signaling functions, and molecular interactions involving p38alpha and one of its downstream signaling partners, mitogen-activated protein kinase-activated protein kinase 2 (MK2), have been explored by steady-state kinetics, surface plasmon resonance, isothermal calorimetry, and stopped-flow fluorescence. Functional 1/1 signaling complexes (Kd = 1-100 nM) composed of activated and nonactivated forms of p38alpha and a splice variant of MK2 (MK2a) were characterized. Catalysis of MK2a phosphorylation and activation by p38alpha was observed to be efficient under conditions where substrate is saturating (kcat(app) = 0.05-0.3 s(-1)) and nonsaturating (kcat(app)/KM(app) = 1-3 x 10(6) M(-1) s(-1)). Specific interactions between the carboxy-terminal residues of MK2a (370-400) and p38alpha precipitate formation of a high-affinity complex (Kd = 20 nM); the p38alpha-dependent MK2a phosphorylation reaction was inhibited by the 30-amino acid docking domain peptide of MK2a (IC50 = 60 nM). The results indicate that the 30-amino acid docking domain peptide of MK2a is required for the formation of a tight, functional p38alpha.MK2a complex, and that perturbation of the tight-docking interaction between these signaling partners prevents the phosphorylation of MK2a. The thermodynamic and steady-state kinetic characterization of the p38alpha.MK2a signaling complex has led to a clear understanding of complex formation, catalysis, and function on the molecular level.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287722     DOI: 10.1021/bi049508v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Targeting diverse signaling interaction sites allows the rapid generation of bivalent kinase inhibitors.

Authors:  Zachary B Hill; B Gayani K Perera; Simeon S Andrews; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2011-12-22       Impact factor: 5.100

2.  MAPKAP kinase MK2 maintains self-renewal capacity of haematopoietic stem cells.

Authors:  Jessica Schwermann; Chozhavendan Rathinam; Maria Schubert; Stefanie Schumacher; Fatih Noyan; Haruhiko Koseki; Alexey Kotlyarov; Christoph Klein; Matthias Gaestel
Journal:  EMBO J       Date:  2009-04-16       Impact factor: 11.598

Review 3.  Molecular basis of MAP kinase regulation.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

4.  Allosteric enhancement of MAP kinase p38α's activity and substrate selectivity by docking interactions.

Authors:  Yuji Tokunaga; Koh Takeuchi; Hideo Takahashi; Ichio Shimada
Journal:  Nat Struct Mol Biol       Date:  2014-07-20       Impact factor: 15.369

5.  Characterization of a novel MK3 splice variant from murine ventricular myocardium.

Authors:  Nadège Moïse; Dharmendra Dingar; Aida M Mamarbachi; Louis R Villeneuve; Nada Farhat; Matthias Gaestel; Maya Khairallah; Bruce G Allen
Journal:  Cell Signal       Date:  2010-06-04       Impact factor: 4.315

6.  Early zebrafish development: it's in the maternal genes.

Authors:  Elliott W Abrams; Mary C Mullins
Journal:  Curr Opin Genet Dev       Date:  2009-07-14       Impact factor: 5.578

7.  Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro.

Authors:  Bart S Hendriks; Kelly M Seidl; Jeffrey R Chabot
Journal:  BMC Syst Biol       Date:  2010-03-15

8.  p38 and OGT sequestration into viral inclusion bodies in cells infected with human respiratory syncytial virus suppresses MK2 activities and stress granule assembly.

Authors:  Jens Fricke; Lily Y Koo; Charles R Brown; Peter L Collins
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

9.  MAPK-activated protein kinase 2 differentially regulates plasmodium falciparum glycosylphosphatidylinositol-induced production of tumor necrosis factor-{alpha} and interleukin-12 in macrophages.

Authors:  Jianzhong Zhu; Xianzhu Wu; Suchi Goel; Nagaraj M Gowda; Sanjeev Kumar; Gowdahalli Krishnegowda; Gourav Mishra; Rebecca Weinberg; Guangfu Li; Matthias Gaestel; Tatsushi Muta; D Channe Gowda
Journal:  J Biol Chem       Date:  2009-04-09       Impact factor: 5.157

10.  Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25.

Authors:  Sylvain Huard; Robert T Elder; Dong Liang; Ge Li; Richard Y Zhao
Journal:  J Virol       Date:  2007-12-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.